{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:02:49Z","timestamp":1791039769242,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1053\/snuc.2002.31769","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T19:08:29Z","timestamp":1149188909000},"page":"123-132","source":"Crossref","is-referenced-by-count":224,"title":["Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies"],"prefix":"10.1053","volume":"32","author":[{"given":"Lowell B.","family":"Anthony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene A.","family":"Woltering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Espenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele D.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/snuc.2002.31769_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/endo-83-4-783","article-title":"Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro","volume":"83","author":"Krulich","year":"1968","journal-title":"Endocrinology"},{"key":"10.1053\/snuc.2002.31769_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.179.4068.77","article-title":"Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone","volume":"179","author":"Brazeau","year":"1973","journal-title":"Science"},{"key":"10.1053\/snuc.2002.31769_bib3","first-page":"6977","article-title":"Oncological applications of somatostatin analogues [published erratum appears in Cancer Res 49:1618, 1989]","volume":"48","author":"Schally","year":"1988","journal-title":"Cancer Res"},{"key":"10.1053\/snuc.2002.31769_bib4","first-page":"838","article-title":"Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides","volume":"43","author":"Raynor","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1053\/snuc.2002.31769_bib5","first-page":"385","article-title":"Characterization of cloned somatostatin receptors SSTR4 and SSTR5","volume":"44","author":"Raynor","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1053\/snuc.2002.31769_bib6","first-page":"1148","article-title":"Postreceptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis","volume":"116","author":"Patel","year":"1994","journal-title":"Surg"},{"key":"10.1053\/snuc.2002.31769_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.256.5060.1215","article-title":"G Protein activation of a hormone-stimulated phosphatase in human tumor cells","volume":"256","author":"Pan","year":"1992","journal-title":"Science"},{"key":"10.1053\/snuc.2002.31769_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0303-7207(92)90146-W","article-title":"Inhibitory effect of somatostatin on cAMP accumulation and calcitonin secretion in C-cells: Involvement of pertussis toxin-sensitive G-proteins","volume":"86","author":"Zink","year":"1992","journal-title":"Mol Cell Endocrinol"},{"key":"10.1053\/snuc.2002.31769_bib9","first-page":"897","article-title":"Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas","volume":"138","author":"Hsu","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1053\/snuc.2002.31769_bib10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0021-9258(17)35249-3","article-title":"Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta cell","volume":"266","author":"Hsu","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1053\/snuc.2002.31769_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000180970","article-title":"Somatostatin receptors in normal and tumoral tissue","volume":"29","author":"Reubi","year":"1988","journal-title":"Horm Res"},{"key":"10.1053\/snuc.2002.31769_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(89)91258-0","article-title":"Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin","volume":"1","author":"Krenning","year":"1989","journal-title":"Lancet"},{"key":"10.1053\/snuc.2002.31769_bib13","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM199011013231805","article-title":"Somatostatin-receptor imaging in the localization of endocrine tumors [see comments]","volume":"323","author":"Lamberts","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/snuc.2002.31769_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/snuc.2002.31769_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ijc.2910560513","article-title":"High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction?","volume":"56","author":"Reubi","year":"1994","journal-title":"Int J Cancer"},{"issue":"suppl 1","key":"10.1053\/snuc.2002.31769_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0026-0495(96)90077-3","article-title":"Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels","volume":"45","author":"Reubi","year":"1996","journal-title":"Metab Clin Exp"},{"key":"10.1053\/snuc.2002.31769_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-4804(91)90186-P","article-title":"Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane","volume":"50","author":"Woltering","year":"1991","journal-title":"J Surg Res"},{"key":"10.1053\/snuc.2002.31769_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1005774713202","article-title":"Somatostatin analogs: Angiogenesis inhibitors with novel mechanisms of action","volume":"15","author":"Woltering","year":"1997","journal-title":"Invest New Drugs"},{"key":"10.1053\/snuc.2002.31769_bib19","first-page":"A2109","article-title":"Octreotide inhibits endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane and in the rat cornea (Meeting abstract)","volume":"34","author":"Danesi","year":"1993"},{"issue":"suppl 1","key":"10.1053\/snuc.2002.31769_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0026-0495(96)90080-3","article-title":"The effects of the somatostatin analog octreotide on angiogenesis in vitro","volume":"45","author":"Danesi","year":"1996","journal-title":"Metab Clin Exp"},{"key":"10.1053\/snuc.2002.31769_bib21","first-page":"265","article-title":"Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995)","volume":"3","author":"Danesi","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1053\/snuc.2002.31769_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2307\/3579495","article-title":"Strand breaks after the decay of iodine-125 in proximity to plasmid pBR322 DNA","volume":"147","author":"Sahu","year":"1997","journal-title":"Radiat Res"},{"key":"10.1053\/snuc.2002.31769_bib23","first-page":"2002","article-title":"Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide","volume":"37","author":"Andersson","year":"1996","journal-title":"J Nucl Med"},{"issue":"suppl 1","key":"10.1053\/snuc.2002.31769_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000201382","article-title":"Internalisation of isotope-coupled somatostatin analogues","volume":"57","author":"Hofland","year":"1996","journal-title":"Digestion"},{"key":"10.1053\/snuc.2002.31769_bib25","first-page":"1514","article-title":"Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors [see comments]","volume":"41","author":"Janson","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2002.31769_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0006-2952(94)90438-3","article-title":"Internalization and nuclear localization of peptide hormones","volume":"47","author":"Morel","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/snuc.2002.31769_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/028418699431483","article-title":"In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex","volume":"38","author":"Lukinius","year":"1999","journal-title":"Acta Oncol"},{"key":"10.1053\/snuc.2002.31769_bib28","first-page":"1256","article-title":"Progressive nuclear translocation of somatostatin analogs","volume":"41","author":"Hornick","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2002.31769_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/jsre.1998.5313","article-title":"Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity","volume":"76","author":"Meyers","year":"1998","journal-title":"J Surg Res"},{"key":"10.1053\/snuc.2002.31769_bib30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<738::AID-IJC20>3.0.CO;2-Z","article-title":"Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies. Evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model","volume":"76","author":"Behr","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1053\/snuc.2002.31769_bib31","first-page":"2089","article-title":"Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: Comparison of Auger electron emitters with beta-particle emitters","volume":"41","author":"Govindan","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2002.31769_bib32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1749-6632.1994.tb17300.x","article-title":"Radiotherapy with a radiolabeled somatostatin analogue [111In- DTPA-D-Phe1]-octreotide. A case history","volume":"733","author":"Krenning","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/snuc.2002.31769_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00007611-200093080-00015","article-title":"High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor","volume":"93","author":"Meyers","year":"2000","journal-title":"South Med J"},{"key":"10.1053\/snuc.2002.31769_bib34","first-page":"94","article-title":"In situ radiotherapy with 111In-pentetreotide: Initial observations and future directions","volume":"4","author":"McCarthy","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1053\/snuc.2002.31769_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-0115(00)00167-1","article-title":"Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors","volume":"96","author":"Desai","year":"2001","journal-title":"Regul Pept"},{"key":"10.1053\/snuc.2002.31769_bib36","series-title":"Accomplishments in Cancer Research 1987","first-page":"295","article-title":"Progress and hope in the treatment of gastrointestinal cancer","author":"Moertel","year":"1988"},{"key":"10.1053\/snuc.2002.31769_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02841869309083912","article-title":"Metastatic carcinoid tumors and the malignant carcinoid syndrome","volume":"32","author":"Kvols","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1053\/snuc.2002.31769_bib38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/00042737-199910000-00014","article-title":"Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): Pharmacological MIBG, 131I-labelled MIBG and the combination","volume":"11","author":"Zuetenhorst","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/snuc.2002.31769_bib39","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V96.4.1259","article-title":"Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: Updated results and long-term follow-up of the University of Michigan experience","volume":"96","author":"Kaminski","year":"2000","journal-title":"Blood"},{"key":"10.1053\/snuc.2002.31769_bib40","first-page":"1519","article-title":"Systemic radionuclide therapy using indium-111-DTPA-D-Phel-octreotide in midgut carcinoid syndrome","volume":"37","author":"Fjalling","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/snuc.2002.31769_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/028418699431465","article-title":"Treatment with high dose [(111)In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors\u2014evaluation of therapeutic and toxic effects","volume":"38","author":"Tiensuu Janson","year":"1999","journal-title":"Acta Oncol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299802800307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299802800307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T22:40:32Z","timestamp":1627425632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299802800307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0001299802800307"],"URL":"https:\/\/doi.org\/10.1053\/snuc.2002.31769","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}